The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 05, 2022

Filed:

Jul. 31, 2018
Applicant:

Rani Therapeutics, Llc, San Jose, CA (US);

Inventors:

Mercedes Morales, San Francisco, CA (US);

Mir Imran, Los Altos Hills, CA (US);

Radhika Korupolu, Fremont, CA (US);

Mir Hashim, Fremont, CA (US);

Assignee:

RANI THERAPEUTICS, LLC, San Jose, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/28 (2006.01); C07K 16/24 (2006.01); A61K 9/20 (2006.01); A61K 38/26 (2006.01); C07K 16/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/28 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2031 (2013.01); A61K 9/2072 (2013.01); A61K 9/2077 (2013.01); A61K 38/26 (2013.01); C07K 16/00 (2013.01); C07K 16/241 (2013.01); C07K 16/244 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/76 (2013.01);
Abstract

Embodiments of the invention provide shaped masses comprising one or more drugs such as proteins or polypeptides and methods for forming such shaped masses. One embodiment provides a shaped mass comprising a drug such as a protein or polypeptide having a biological activity in the body of a mammal. The shaped mass is formed by compression of a precursor material comprising the drug wherein an amount of biologically active drug in the mass is a preserved above a minimum level. Drugs which may be incorporated into the shaped mass may include one or more glucose regulating proteins such as insulin, incretins; and immunoglobulins such as TNF-inhibiting antibodies or interleukin neutralizing antibodies. Embodiments of the shaped mass may be incorporated into a tissue penetrating member which is inserted into the intestinal wall allowing for the oral delivery of proteins and peptides which would otherwise be degraded in the intestinal tract.


Find Patent Forward Citations

Loading…